Mostrar el registro sencillo del ítem
dc.contributor.author
Crisp, Renée
dc.contributor.author
Grillé, Sofía
dc.contributor.author
Belli, Carolina Bárbara
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.contributor.author
Diaz, Lilian
dc.contributor.author
Undurraga, Soledad
dc.contributor.author
Navarro, Juan
dc.contributor.author
Vidal, Gabriela
dc.contributor.author
Gusmao, Breno
dc.contributor.author
Reyes, Jheremy
dc.contributor.author
Huaman Garaicoa, Fuad
dc.contributor.author
Magalhaes, Silvia
dc.contributor.author
Barroso, Fernando
dc.contributor.author
Ovilla, Roberto
dc.contributor.author
Flores, Gabriela
dc.contributor.author
Choque, Juan
dc.contributor.author
Distéfano, Marcos
dc.contributor.author
Salinas Viedma, Victor
dc.contributor.author
Iastrebner, Marcelo
dc.date.available
2020-01-27T22:57:19Z
dc.date.issued
2018-12
dc.identifier.citation
Crisp, Renée; Grillé, Sofía; Belli, Carolina Bárbara; Diaz, Lilian; Undurraga, Soledad; et al.; Myelodysplastic syndromes in Latin America: State of the art; American Society of Hematology; Blood Advances; 2; 12-2018; 60-62
dc.identifier.issn
2473-9529
dc.identifier.uri
http://hdl.handle.net/11336/95945
dc.description.abstract
Latin America is a group of countries that covers an area of approximately 19 197 000 km2. In 2016, itspopulation was estimated at more than 639 million. The prevalent languages are Spanish andPortuguese.Myelodysplastic syndromes (MDSs) are a heterogeneous group of myeloid neoplasms characterized byabnormal differentiation and maturation of myeloid cells, bone marrow failure, and genetic instability withenhanced risk of transforming to acute myeloid leukemia.The incidence rates for MDS in Europe and the United States range from 3 to 5 per 100 000 personyearsand increase markedly with age to 20 per 100 000 person-years for those older than age 70 years.Despite the absence of epidemiologic data, Latin America also has an aging population, as with otherdeveloped countries, and an increasing rate of secondary MDS from previous toxic exposure not only asa consequence of treating other malignancies but also as a result of environmental or occupationalfactors. Diagnosis and treatment remain difficult because of the high number of economic andtechnological disparities within and among Latin American countries.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
American Society of Hematology
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
Myelodysplastic Syndromes
dc.subject
Latinamerica
dc.subject
GLAM
dc.subject
Grupo Latinoamericano de Mielodisplasia
dc.subject.classification
Hematología
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.subject.classification
Medicina Clínica
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.title
Myelodysplastic syndromes in Latin America: State of the art
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2019-10-18T18:03:32Z
dc.identifier.eissn
2473-9537
dc.journal.volume
2
dc.journal.pagination
60-62
dc.journal.pais
Estados Unidos
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.journal.ciudad
Washington DC
dc.description.fil
Fil: Crisp, Renée. Hospital Nacional "a Posadas"; Argentina
dc.description.fil
Fil: Grillé, Sofía. Hospital de Clínicas; Uruguay
dc.description.fil
Fil: Belli, Carolina Bárbara. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina
dc.description.fil
Fil: Diaz, Lilian. Hospital de Clínicas; Uruguay
dc.description.fil
Fil: Undurraga, Soledad. Hospital El Salvador; Chile
dc.description.fil
Fil: Navarro, Juan. Hospital Nacional Edgardo Rebagliati Martins; Perú
dc.description.fil
Fil: Vidal, Gabriela. Hospital Nacional Edgardo Rebagliati Martins; Perú
dc.description.fil
Fil: Gusmao, Breno. Hospital Israelita Albert Einstein; Brasil
dc.description.fil
Fil: Reyes, Jheremy. Clínica Los Nogales; Colombia
dc.description.fil
Fil: Huaman Garaicoa, Fuad. Instituto Oncológico Nacional Dr. J. Tanca Marengo; Ecuador
dc.description.fil
Fil: Magalhaes, Silvia. Universidade Federal Do Ceara; Brasil
dc.description.fil
Fil: Barroso, Fernando. Universidade Estadual do Ceará; Brasil
dc.description.fil
Fil: Ovilla, Roberto. Hospital Angeles Lomas; México
dc.description.fil
Fil: Flores, Gabriela. Gobierno de Ciudad de Buenos Aires. Hospital General de Agudos "Carlos G. Durand"; Argentina
dc.description.fil
Fil: Choque, Juan. Hospital de Especialidades Materno Infantil; Bolivia
dc.description.fil
Fil: Distéfano, Marcos. Hospital Domingo Luciani; Venezuela
dc.description.fil
Fil: Salinas Viedma, Victor. Instituto de Prevision Social; Paraguay
dc.description.fil
Fil: Iastrebner, Marcelo. Sanatorio Sagrado Corazón; Argentina
dc.journal.title
Blood Advances
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1182/bloodadvances.2018GS110862
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://ashpublications.org/bloodadvances/article/2/Supplement_1/60/422707/Myelodysplastic-syndromes-in-Latin-America-state
Archivos asociados